We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Stride
LRN
$3.43B
| $1.88M | ﹤0.01% |
62,399
-7,373
| -11% | -$191K |
|
1952
Enterprise Financial Services Corp
EFSC
$2.39B
| $1.87M | ﹤0.01% |
37,827
-2,207
| -6% | -$92.9K |
|
1953
ATN International
ATNI
$492M
| $1.87M | ﹤0.01% |
38,045
+463
| +1% | +$21.9K |
|
1954
Brookdale Senior Living
BKD
$3.4B
| $1.86M | ﹤0.01% |
307,551
-22,583
| -7% | -$122K |
|
1955
Playtika
PLTK
$1.12B
| $1.86M | ﹤0.01% |
+68,331
| New | +$2.01M |
|
|
KREF
1956
KKR Real Estate Finance Trust
KREF
$499M
| $1.86M | ﹤0.01% |
101,014
-1,871
| -2% | -$34.3K |
|
|
UBA
1957
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $1.85M | ﹤0.01% |
111,252
+1,253
| +1% | +$19.7K |
|
1958
PJT Partners
PJT
$4.38B
| $1.84M | ﹤0.01% |
27,250
-2,664
| -9% | -$193K |
|
|
OCDX
1959
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $1.83M | ﹤0.01% |
+95,121
| New | +$1.68M |
|
|
CNSL
1960
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $1.83M | ﹤0.01% |
254,574
+5,294
| +2% | +$31.5K |
|
1961
Upstart Holdings
UPST
$3.03B
| $1.83M | ﹤0.01% |
+14,205
| New | +$1.09M |
|
1962
iShares S&P 500 Growth ETF
IVW
$77.6B
| $1.81M | ﹤0.01% |
27,880
| – | – |
|
1963
Conduent
CNDT
$264M
| $1.81M | ﹤0.01% |
272,134
-17,963
| -6% | -$102K |
|
1964
Central Garden & Pet Co
CENT
$2.8B
| $1.81M | ﹤0.01% |
39,018
+540
| +1% | +$20.3K |
|
|
SGMO
1965
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.81M | ﹤0.01% |
144,510
-12,117
| -8% | -$163K |
|
1966
Groupon
GRPN
$1.02B
| $1.81M | ﹤0.01% |
35,794
-4,096
| -10% | -$177K |
|
1967
Phreesia
PHR
$773M
| $1.8M | ﹤0.01% |
34,556
-2,714
| -7% | -$171K |
|
1968
Sphere Entertainment
SPHR
$5.73B
| $1.8M | ﹤0.01% |
21,999
-499
| -2% | -$49.7K |
|
|
RUBY
1969
DELISTED
Rubius Therapeutics, Inc
RUBY
| $1.77M | ﹤0.01% |
66,841
+7,585
| +13% | +$111K |
|
1970
Johnson Outdoors
JOUT
$505M
| $1.77M | ﹤0.01% |
12,381
-2,326
| -16% | -$293K |
|
1971
GoPro
GPRO
$126M
| $1.76M | ﹤0.01% |
151,639
-11,799
| -7% | -$111K |
|
1972
Axsome Therapeutics
AXSM
$10.9B
| $1.74M | ﹤0.01% |
30,732
-4,968
| -14% | -$349K |
|
1973
Relay Therapeutics
RLAY
$4.33B
| $1.74M | ﹤0.01% |
50,282
+9,902
| +25% | +$430K |
|
1974
Yext
YEXT
$574M
| $1.73M | ﹤0.01% |
119,546
-8,414
| -7% | -$140K |
|
1975
1st Source
SRCE
$2.12B
| $1.73M | ﹤0.01% |
36,289
-1,480
| -4% | -$65.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.